Francisca Elena Zavaleta Gutiérrez

Francisca Elena Zavaleta Gutiérrez

Auto-generated profile, based on publicly available information

Francisca Elena Zavaleta Gutiérrez

Division of Neonatology, Hospital Belén de Trujillo, Trujillo, Peru

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2023 in World Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
MCMarcio José Concepción-Zavaleta
Marcio José Concepción-Zavaleta
JQJuan Eduardo Quiroz-Aldave
Juan Eduardo Quiroz-Aldave
MDMaría del Carmen Durand-Vásquez
María del Carmen Durand-Vásquez
EGElman Rolando Gamarra-Osorio
Elman Rolando Gamarra-Osorio
JCJuan del Carmen Valencia de la Cruz
Juan del Carmen Valencia de la Cruz
JPJosé Paz-Ibarra
José Paz-Ibarra

22 November 2020 in International Journal of Epidemiology
Verified
Journal Article
Closed access
MCMarcio José Concepción-Zavaleta
Marcio José Concepción-Zavaleta
JCJulia Cristina Coronado-Arroyo
Julia Cristina Coronado-Arroyo
FZFrancisca Elena Zavaleta-Gutiérrez
Francisca Elena Zavaleta-Gutiérrez
LCLuis Alberto Concepción-Urteaga
Luis Alberto Concepción-Urteaga

30 June 2023 in Annals of Pediatric Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
MCMarcio José Concepción-Zavaleta
Marcio José Concepción-Zavaleta
CACristian David Armas
Cristian David Armas
JQJuan Eduardo Quiroz-Aldave
Juan Eduardo Quiroz-Aldave
EGEilhart Jorge García-Villasante
Eilhart Jorge García-Villasante
AGAna Cecilia Gariza-Solano
Ana Cecilia Gariza-Solano
FZFrancisca Elena Zavaleta-Gutiérrez
Francisca Elena Zavaleta-Gutiérrez
Cushing disease (CD) is the main cause of endogenous Cushing syndrome (CS) and is produced by an adrenocorticotropic hormone (ACTH)-producing pituitary adenoma. Its relevance in pediatrics is due to the retardation of both growth and developmental processes because of hypercortisolism. In childhood, the main features of CS are facial changes, rapid or exaggerated weight gain, hirsutism, virilization, and acne. Endogenous hypercortisolism should be established after exogenous CS has been ruled out based on 24-hour urinary free cortisol, midnight serum or salivary cortisol, and dexamethasone suppression test; after that, ACTH dependence should be established. The diagnosis should be confirmed by pathology. The goal of treatment is to normalize cortisol level and reverse the signs and symptoms. Treatment options include surgery, medication, radiotherapy, or combined therapy. CD represents a challenge for physicians owing to its multiple associated conditions involving growth and pubertal development; thus, it is important to achieve an early diagnosis and treatment in order to control hypercortisolism and improve the prognosis. Its rarity in pediatric patients has led physicians to have limited experience in its management. The objective of this narrative review is to summarize the current knowledge about the pathophysiology, diagnosis, and treatment of CD in the pediatric population.

21 September 2020 in Obesity
Verified
Journal Article
Open access
PDF file
MCMarcio José Concepción‐Zavaleta
Marcio José Concepción‐Zavaleta
CGClaudia Gutiérrez-Ortiz
Claudia Gutiérrez-Ortiz
JCJulia Cristina Coronado‐Arroyo
Julia Cristina Coronado‐Arroyo
FZFrancisca Elena Zavaleta‐Gutiérrez
Francisca Elena Zavaleta‐Gutiérrez
LCLuis Alberto Concepción‐Urteaga
Luis Alberto Concepción‐Urteaga
We have read with great interest the prospective cohort study published by Czernichow et al 1, wherein they found that obesity doubles mortality in patients hospitalized with coronavirus disease (COVID‐19), using as an indicator anthropometric, the body mass index (BMI). Despite BMI being recognized as an anthropometric index of obesity and various studies confirming that it predicts cardiovascular events, the lack of information it provides on the distribution of body fat is considered its main limitation. The use of abdominal circumference and waist‐height ratio are better measures of visceral fat distribution, which is more closely associated with cardiometabolic risk;2 however, those measures demand greater contact with COVID‐19 patients.

29 June 2021 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
MZMarcio José Concepción Zavaleta
Marcio José Concepción Zavaleta
JAJulia Cristina Coronado Arroyo
Julia Cristina Coronado Arroyo
FGFrancisca Elena Zavaleta Gutiérrez
Francisca Elena Zavaleta Gutiérrez
LULuis Alberto Concepción Urteaga
Luis Alberto Concepción Urteaga

14 October 2020 in Journal of Public Health
Verified
Journal Article
Closed access
MCMarcio José Concepción-Zavaleta
Marcio José Concepción-Zavaleta
DMDiego Moreno Marreros
Diego Moreno Marreros
JAJulia Cristina Coronado Arroyo
Julia Cristina Coronado Arroyo
LULuis Alberto Concepción Urteaga
Luis Alberto Concepción Urteaga
FGFrancisca Elena Zavaleta Gutiérrez
Francisca Elena Zavaleta Gutiérrez